A device for handling a particle suspension, in particular a cell suspension, which includes at least one channel for flowing the particle suspension, a pumping unit configured to move a driving fluid and control element for controlling the pumping unit. Also, a method for handling a particle suspension, which includes flowing the particle suspension in or out of at least one channel using a driving fluid for driving the particle suspension in the channel.

Disclosed are methods and kits for analyzing a sample comprising 1,5-anhydroglucitol and a possible first analyte via one or more chemiluminescent reactions. Certain embodiments include measuring a first light response resulting from a first chemiluminescent reaction and measuring a second light response resulting from a second chemiluminescent reaction. Certain embodiments also include comparing the first light response to the second light response to determine a ratio of 1,5-anhydroglucitol and the first analyte. Also provided are kits including reagents for practicing the claimed methods.

A carbonation machine may include a carbonation head, a holder that is configured to hold a gas canister, the holder comprising a connector with a socket configured to enable linear insertion of a valve of the canister into the socket, the socket including a seal with at least one lateral opening to enable fluidic flow between one or more laterally oriented ports of the valve and a conduit of the holder while preventing leakage of gas from the fluidic flow, and a holding mechanism configured to hold a lateral projection from the canister after insertion of the valve into the socket such that the valve remains in the socket, and an activation mechanism configured to operate the valve to release the gas from the canister when inserted into the socket so as to enable the gas to flow via the conduit to the carbonation head.

An online pulverized coal concentration regulator is mounted at a front end of a pulverized coal pipe, and a pulverized coal concentration detector is arranged in the pipe. The regulator includes a control system, and an output of the concentration detector is connected with a signal input end of the control system. The regulator includes a top plate, a regulating rod, and a powder baffle plate. A mounting hole for fixedly mounting the front end of the pipe and a through hole for the powder baffle plate to penetrate through are arranged in the top plate, and a connector is arranged between the regulating rod and the powder baffle plate. The regulator includes a guider slidably connected with the powder baffle plate and fixedly connected with the top plate, and a diversion plate arranged on the top plate and slidably connected with the powder baffle plate.

Disclosed herein is a molecular imprinted protective face mask comprising a supportive structure, a surface material that receives and retains a molecular imprint and that is positioned to contact airborne molecules during use, a molecular imprint of a bioactive molecule wherein an imprinted cavity is at least one of a bioactive molecule with a molecular configuration that captures a specific airborne and/or microdroplet-borne molecule and a protein with a binding site that captures a specific molecule.

The present invention relates to a biochemical assay apparatus in which a sample processing device is controlled by a detection instrument through a series of linear and rotary actuations to execute a biochemical assay on a biological fluid sample.

A multifunctional C.sub.4F.sub.7N/CO.sub.2 mixed gas preparation system is disclosed. The C.sub.4F.sub.7N heat exchanger is used to heat and vaporize C.sub.4F.sub.7N input through the C.sub.4F.sub.7N input port; the CO.sub.2 heat exchanger is used to heat and vaporize CO.sub.2 input through the CO.sub.2 input port; the C.sub.4F.sub.7N/CO.sub.2 mixing pipeline structure is used to mix the heated C.sub.4F.sub.7N and heated CO.sub.2, and the C.sub.4F.sub.7N/CO.sub.2 mixed gas output pipeline structure is used to output the C.sub.4F.sub.7N/CO.sub.2 mixed gas. The C.sub.4F.sub.7N/CO.sub.2 mixing pipeline structure comprises a C.sub.4F.sub.7N/CO.sub.2 dynamic gas preparation pipeline structure and a C.sub.4F.sub.7N/CO.sub.2 partial pressure mixing pipeline structure; the C.sub.4F.sub.7N/CO.sub.2 partial pressure mixing pipeline structure includes partial pressure mixing tanks for mixing the CO.sub.2 and the heated C.sub.4F.sub.7N of certain pressures; and a plurality of partial pressure mixing tanks are arranged in parallel. A multifunctional C.sub.4F.sub.7N/CO.sub.2 mixed gas preparation method is also disclosed.

The method of obtaining stable suspensions of heterocrystals of titanium dioxide and particles of silicon dioxide representing special class of quantum dots (QD). and stable suspensions obtained in such a way for initiation of active form of oxygen in the human body in use in medical forms. Starting material: Initial stuff in the form of aggregates with size more than 0.5 micrometer is mixed with an aqueous solution of pharmaceutical inorganic acid, with subsequent direction to homogenizing for the first stage of mixing, after that the obtained aqueous suspension is subjected to thermal treatment and, then aqueous suspension is directed to the rotary rotor-type evaporator periodically for evaporation of inorganic acid with suspension expense trough the rotor-type evaporator no more than 25 l/min and then the obtained activated particles are mixed with water in hydrodynamical cavitation-wave cavitational homogenizer to quasi-with regulated pulsating wave mode until obtaining stable suspension of heterocrystal of titanium dioxide or particles of silicon dioxide with size less than 450 nm, and presence on the lattice surface up to 60-80% of electronically-excited triplet oxygen .sup.3+TO.sub.23O2 in the energy centers, namely, in the quantum dotszones of local overheating, ensuring heat synthesis catalytic activity for formation of active forms of oxygen in the living organism human body.

The surface of Stable suspension obtained by said method is characterized by distribution of activated crystals of titanium dioxide or with size up to 1 nm being 0.3 vol %, up to 20 nm being 5-40 vol %, particles with size up to 80 nm being 10-80 vol %, particles with size up to 150 nm being 5-30 vol %, particles with size up to 250 nm being 5-20 vol %, particles with size more than 250 nm-no more than 10 vol %, and distribution of activated particles of silicon dioxide with size 40-80 nm being 10-80 vol %, particles with size 80-150 nm being 10-80 vol %, particles with size 150-250 nm being less than 30 vol %, particles with size more than 250 nmno more than 15%. The surface of heterocrystals of titanium dioxide and particles of silicon dioxide has sorption ability, that is an important factor for use in medical forms, ensuring detoxication of an organism, elimination of hypoxia, antiviral effect of a medical agent, antipathogenous effect in the body of living organism and elimination of under oxidation processes in the human body, increasing induction of immune response of vertebrata.

Systems and methods are described for dissolving ammonia gas in deionized water. The system includes a deionized water source and a gas mixing device including a first inlet for receiving ammonia gas, a second inlet for receiving a transfer gas, and a mixed gas outlet for outputting a gas mixture comprising the ammonia gas and the transfer gas. The system includes a contactor that receives the deionized water and the gas mixture and generates deionized water having ammonia gas dissolved therein. The system includes a sensor in fluid communication with at least one inlet of the contactor for measuring a flow rate of the deionized water, and a controller in communication with the sensor. The controller sets a flow rate of the ammonia gas based on the flow rate of the deionized water measured by the sensor, and a predetermined conductivity set point.

The present invention provides methods and devices for simple, low power, automated processing of biological samples through multiple sample preparation and assay steps. The methods and devices described facilitate the point-of-care implementation of complex diagnostic assays in equipment-free, non-laboratory settings.